Namap 1000mg Injection

Namap 1000mg Injection is an antibiotic used to prevent or treat a wide variety of bacterial infections. This may include infections of the urinary tract, blood, brain, ear, skin, and soft tissue, abdomen, bone, windpipe and lungs.

Namap 1000mg Injection is given as a drip (intravenous infusion) or as an injection directly into a vein or a muscle under the supervision of a healthcare professional. It should be used regularly at evenly spaced time intervals as prescribed by your doctor. Do not skip any doses and finish the full course of treatment even if you feel better. Stopping the medicine too early may lead to the infection returning or worsening.

Rash, vomiting, nausea, and diarrhea may be seen as the most common side effects. Temporary pain, swelling, and redness at the injection site may also occur at the injection site. Consult your doctor if any of these side effects persist or if your condition does not improve despite treatment.

Inform your doctor if you have any previous history of allergy or heart problems before taking this medicine. Pregnant or breastfeeding women should consult their doctor before using this medicine.

• Severe bacterial infections

Severe bacterial infections
Namap 1000mg Injection works by killing bacteria which can cause serious infections. It is used to treat many different types of bacterial infections such as infections of lungs (pneumonia), blood, brain, ear, skin, and soft tissue, abdomen, bone, windpipe and urinary tract. It is given by a doctor or nurse into a vein and should not be self-administered. Namap 1000mg Injection usually makes you feel better very quickly but you should continue taking it as prescribed even when you feel better to make sure that all bacteria are killed and do not become resistant.

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Ftreonam

• Rash
• Injection site reactions (pain, swelling, redness)
• Vomiting
• Nausea
• Diarrhea

Your doctor or nurse will give you this medicine. Kindly do not self administer.

Namap 1000mg Injection is an antibiotic. It kills bacteria by preventing them from forming the bacterial protective covering (cell wall) which is needed for them to survive.

• You have been prescribed Namap 1000mg Injection for the treatment of bacterial infections.
• It is given by an injection or drip into a vein or into a muscle in the buttock or thigh.
• Finish the prescribed course, even if you start to feel better. Stopping it early may make the infection come back and harder to treat.
• Diarrhea may occur as a side effect but should stop when your course is complete. Inform your doctor if it doesn't stop or if you find blood in your stools.
• Inform your doctor immediately if you develop an itchy rash, swelling of the face, throat or tongue or breathing difficulties while taking this medicine.
• Inform your doctor if you are pregnant, planning to conceive or breastfeeding.

Petri WA Jr. Penicillins, Cephalosporins, and Other β -Lactam Antibiotics. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1500-501.

Chambers HF, Dech DH. Beta-Lactam Antibiotics & Other Cell Wall Synthesis Inhibitors. In: Trevor AJ, Katzung BG, Kruidering-Hall M, editors. Katzung & Trevor's Pharmacology: Examination & Board Review. 11 th ed. McGraw-Hill Education: New York, New York; 2015. [Accessed 23 Jan. 2019] (online) Available from:

Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 120.

Drugs.com. Aztreonam. [Accessed 05 Feb. 2019] (online) Available from:

Aztreonam. Princeton, NJ: Bristol-Myers Squibb; . [Accessed 29 Mar. 2019] (online) Available from:

Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-98. [Accessed 29 Mar. 2019] (online) Available from:

Central Drugs Standard Control Organisation (CDSCO). [Accessed 28 Mar. 2019] (online) Available from: